Bromocriptine is a sympatholytic dopamine D2 receptor agonist with remarkable
bioactivities. It has been used clinically as a prescription drug for more than 30 years to treat …

Type 2 diabetes (T2D) is a commonly diagnosed condition that has been extensively
studied. The composition and activity of gut microbes, as well as the metabolites they …

Dopamine is a key regulator of glucose metabolism in the central nervous system. However,
dopamine is also present in the periphery and may have direct effects on insulin-sensitive …

Mental illnesses are a global health challenge, and effective medicines are needed to treat
these conditions. Psychotropic drugs are commonly prescribed to manage mental disorders …

Despite enormous global efforts within clinical research and medical practice to reduce
cardiovascular disease (s)(CVD), it still remains the leading cause of death worldwide. While …

About 10% of the adult population is living with type 2 diabetes mellitus (T2DM) and 1% of
the population over 60 years of age is suffering from Parkinson's disease (PD). A school of …

Adipocytes express several kinds of catecholamine receptors, including adrenergic
receptors, and dopamine receptors. Signaling pathways mediated by catecholamine …

Robust experiment evidence suggests that prolactin can enhance beta-cell proliferation and
increase insulin secretion and sensitivity. Apart from acting as an endocrine hormone, it also …

Both hyperprolactinemia and vitamin D deficiency appear to be associated with increased
cardiometabolic risk. This study aimed to determine whether vitamin D status influences the …

Aim Genome‐wide association studies (GWAS) have identified multiple susceptibility loci
associated with insulin resistance (IR)‐relevant phenotypes. However, the genes …